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ttp://dx.doi.org/10.1016/j.ajpath.2012.09.011In normal human cells, oncogene-induced senescence (OIS) depends on induction of DNA damage
response. Oxidative stress and hyperreplication of genomic DNA have been proposed as major
causes of DNA damage in OIS cells. Here, we report that down-regulation of deoxyribonucleoside
pools is another endogenous source of DNA damage in normal human ﬁbroblasts (NHFs) under-
going HRASG12V-induced senescence. NHF-HRASG12V cells underexpressed thymidylate synthase (TS)
and ribonucleotide reductase (RR), two enzymes required for the entire de novo deoxyribonucle-
otide biosynthesis, and possessed low dNTP levels. Chromatin at the promoters of the genes
encoding TS and RR was enriched with retinoblastoma tumor suppressor protein and histone H3
tri-methylated at lysine 9. Importantly, ectopic coexpression of TS and RR or addition of deox-
yribonucleosides substantially suppressed DNA damage, senescence-associated phenotypes, and
proliferation arrest in two types of NHF-expressing HRASG12V. Reciprocally, short hairpin RNA-
mediated suppression of TS and RR caused DNA damage and senescence in NHFs, although less
efﬁciently than HRASG12V. However, overexpression of TS and RR in quiescent NHFs did not
overcome proliferation arrest, suggesting that unlike quiescence, OIS requires depletion of dNTP
pools and activated DNA replication. Our data identify a previously unknown role of deoxyribo-
nucleotides in regulation of OIS. (Am J Pathol 2013, 182: 142e151; http://dx.doi.org/10.1016/
j.ajpath.2012.09.011)Supported by NIH grants R01 CA120244 (M.A.N.) and R01
GM073744 (C.K.M.) and American Cancer Society grant RSG-10-121-01
(M.A.N.).Oncogene-induced senescence (OIS) represents an impor-
tant fail-safe mechanism that suppresses proliferation of
premalignant cells.1e3 Compelling evidence suggests that
the response to DNA damage is one of the intrinsic
processes required for the induction of OIS.4e7 It was
shown that aberrant activation of HRAS in human ﬁbro-
blasts induces hyperreplication of genomic DNA, which
leads to alterations in progression of DNA replication fork,
generation of single- and double-strand DNA breaks (SSBs
and DSBs, respectively), and activation of DNA damage
response (DDR).6 SSBs induce DDR by engaging serine/
threonine-protein kinase ATR (ataxia telangiectasia and
Rad3-related protein) that transmits signaling to checkpointstigative Pathology.
.kinase 1 (CHK1).8 CHK1 phosphorylates CDC25 protein,
one of the key regulators of cell cycle progression, and
targets it for degradation.8 DSBs initiate DDR that depends
on another serine/threonine protein kinase, ataxia telangi-
ectasia mutated (ATM).9 Activation of ATM results in
phosphorylation of several targets, including the histone
H2A variant H2AX,10 p53 tumor suppressor,11,12 and
CHK2 kinase.13 Both ATR and ATM signaling pathways
are activated in normal human ﬁbroblasts (NHFs)
dNTP Pools Suppress Senescenceundergoing HRASG12V-induced senescence,4e7 whereas
ATM and CHK2 are required for this senescence because
their individual short hairpin RNA (shRNA)-mediated
inhibition enabled NHFs to overcome proliferation arrest
and other senescence-associated phenotypes.6,7
At the same time, studies conducted in yeasts and
mammalian cells report that stalling of DNA replication fork
and activation of ATR/CHK1 and ATM/CHK2 pathways
can be induced by pharmacologic depletion of all or selected
nucleotide pools.14,15 In the present study, we investigated
endogenous processes that caused DNA damage in human
ﬁbroblasts undergoing OIS and demonstrated that DNA
damage at least partially originates from underexpression of
key enzymes involved in de novo deoxyribonucleoside
biosynthesis and subsequent depletion of endogenous dNTP
pools. We propose that nucleotide deﬁciency caused by
aberrant expression of activated HRAS contributes to OIS.Materials and Methods
Cell Lines and Populations
HNFs WI-38 were purchased from ATCC (Manassas, VA).
BJ-ET-RASG12V-ERTAM ﬁbroblasts were a gift from
Dr. Andrei Gudkov (Roswell Park Cancer Institute, Buffalo,
NY). Cells were cultured in Dulbecco’s modiﬁed Eagle’s
essential minimal medium supplemented with 10% fetal calf
serum, 2 mmol/L glutamine, and 100 U/mL penicillin G
plus 100 mg/mL streptomycin.Lentiviral Constructs and Infection
Lentiviral infection protocols and vectors containing cDNAs
of HRASG12V were described previously.16 pLKO1 vector
containing shRNA for ribonucleotide reductase (RR) 2 was
purchased from Sigma-Aldrich (St. Louis, MO). cDNA for
thymidylate synthase (TS), RR1, and RR2 were ampliﬁed
by reverse transcription polymerase chain reaction from
total RNA isolated from human melanoma cells and cloned
in pLV-SV-puro expression vector (a gift from Dr. Peter
Chumakov, Cleveland Clinic, Cleveland, OH).Assays for Cell Proliferation and Senescence
For the proliferation assay, cells were plated in 96-well plates
at w50% conﬂuence 2 days before the assay. Cells were
incubated with a nucleoside analog of thymidine, 5-ethynyl-
20-deoxyuridine (EdU), for 60 minutes, followed by ﬁxation
and staining for EdU-incorporated cells with the use of the
ClickiT EdU Assay kit (Invitrogen, Carlsbad, CA).
For the senescence assay, cells were plated in 12-well
plates, ﬁxed, and incubated at 37C with staining solution
containing the X-Gal substrate (BioVision, Mountain View,
CA). The development of blue color was detected visually
with a microscope.The American Journal of Pathology - ajp.amjpathol.orgImmunoblot Analysis, Immunoﬂuorescence, and Comet
Assay
For Western blot analysis, antibodies were used for the
following human proteins: ERK1 and phospho-ERK1/2, RR1,
and RR2 from Santa Cruz Biotechnology (Santa Cruz, CA; sc-
42, sc-93, sc-7383, sc-11733, and sc-10844, respectively), TS
(ab7398-1) from Abcam (Cambridge, MA), thymidine kinase
1 (34003) from EMD Chemical Group (San Diego, CA),
and ATM (2873) and phospho-ATM-Ser1981 (4526) from
Cell Signaling Technology (Danvers, MA). Membranes
were developed with alkaline phosphatase-conjugated
secondary antibodies and the a-Innotech FluorChem HD2
imaging system (R&D Systems, Inc., Minneapolis, MN). For
immunoﬂuorescence-based analysis, formaldehyde-ﬁxed cells
were stained with H2AX-gespeciﬁc antibodies (05-636) from
Millipore (Billerica, MA) according to the manufacturer’s
recommendations, followed by staining with DAPI. Alkaline
comet assaywas performedwith Trevigen (Gaithersburg,MD)
CometAssay HT kit (4252-040-K) according to the manufac-
turer’s recommendations.Nucleotide Triphosphate Quantiﬁcation
Nucleotide triphosphates were extracted and assayed as
described previously.17,18 All measurements were performed
in quadruplicate, and data were recorded as SD of the mean.
For convenience, data are presented in the respective ﬁgures
in terms of arbitrary units. However, the actual pool sizes
determined, in pmol/cell, were comparable with values
previously reported for cultured mammalian cells.18Chromatin Immunoprecipitation
Interactions between retinoblastoma (RB) tumor suppressor
protein, tri-methylated lysine 9 of histone H3 (H3K93Me),
and the promoters of TS, RR1, and RR2 were assessed
with the EZ-Chip kit from Millipore according to the manu-
facturer’s recommendations with the following antibodies:
IgG (sc-2027; Santa Cruz Biotechnology), RB (sc-73598;
Santa Cruz Biotechnology), or H3K93Me (07-442;Millipore).
The following primers were used for the PCR: TS, 50-TTC-
CCGGGTTTCCTAAGACT-30 and 50-TGGATCTGCCC-
CAGGTACT-30; RR1, 50-GCTGACAGGGCGGAAG-30
and 50-GGAAGGGGATTTGGATTGTT-30; RR2, 50-CCT-
CACTCCAGCAGCCTTTA-30 and 50-CACCAACCTCGT-
TGGCTAAG-30.Fluorescence-Activated Cell Sorting Analysis
Cells were pelleted, resuspended in phosphate-buffered
saline containing 0.5% fetal calf serum (PBS-S), and ﬁxed
in 70% ethanol. The cells were washed in PBS-S, resus-
pended in PBS-S containing propidium iodide (Sigma-
Aldrich), incubated for 30 minutes at 37C, and analyzed143
Figure 1 Senescent HRASG12V-WI38 ﬁbroblasts possess low NTP pools
and underexpress key enzymes for deoxyribonucleoside metabolism.
A: Cells were infected with empty lentiviral vector (V) or lentiviral vector
encoding HRASG12V (R). Six days after infection, cells were ﬁxed and
processed to visualize SA-b-Gal activity. Numbers indicate a percentage of
SA-b-Galepositive cells. The numbers were derived from counting cells in
multiple view ﬁelds. B: Cells infected as in A were harvested 6 days after
infection, and intracellular NTPs were extracted and quantiﬁed. Amounts of
each NTP were normalized by the amounts of a corresponding NTP detected
in vector cells. C: Cells infected as in A were harvested 6 days after infection
and lysed, and total protein extracts were probed in Western blot analysis
with antibodies shown on the right. D: Cells infected as in A were collected,
ﬁxed, stained with propidium iodide, and analyzed by ﬂow cytometry.
Mannava et alwith a FACScan ﬂuorescence-activated cell sorter (BD
Biosciences, San Jose, CA).
Results
HRASG12V-Overexpressing Senescent WI-38 Cells
Possess Low dNTP Pools and Underexpress Key
Enzymes Required for Deoxyribonucleoside
Biosynthesis
To determine whether NHFs undergoing OIS possessed low
levels of endogenous nucleotide pools, we assessed amounts
of intracellular ribonucleoside and deoxyribonucleoside
triphosphates in WI-38 cells transduced with control or
HRASG12V-expressing lentiviral vector 6 days after infec-
tion, that is, soon after the emergence of senescent pheno-
types (Figure 1A).We found that, although overexpression of
HRASG12V depleted both pools of nucleotide triphosphates,
levels of rNTPs were affected less severely than dNTP levels
(Figure 1B). Unlike de novo ribonucleotide biosynthesis
pathways that includemultiple enzymatic activities, the entire
de novo biosynthesis of deoxyribonucleosides was largely
controlled by only two enzymes. RR converted ADP, CDP,
GDP, and UDP to dADP, dCDP, dGDP, and dUDP,
respectively.19 TS catalyzed the de novo synthesis of dTMP
from dUMP.20 Thus, we measured expression levels of TS
and both subunits of RR (RR1 and RR2) in control and
HRASG12V-expressing WI-38 cells by Western blot analysis
6 days after infection. We found that like dNTP pools, the
levels of these enzymes were signiﬁcantly depleted in sen-
escent ﬁbroblasts (Figure 1C). In addition, the expression of
a gene encoding thymidine kinase 1, a key enzyme required
for the salvage deoxyribonucleoside synthesis,21 was also
down-regulated in senescent cells.
Coexpression of TS, RR1, and RR2 or Addition of
Deoxyribonucleosides Reduces DNA Damage and OIS in
NHFs
The highest expression of TS and RR has been reported in the
S phase of the cell cycle.22,23 Therefore, depletion of TS, RR,
and dNTP pools in HRASG12V-WI-38 cells may have been
a consequence of G0/G1 or G1/S cell cycle arrest induced by
HRASG12V (Figure 1D). Alternatively, this depletion may
have been a cause of proliferation arrest and senescence
in cells overexpressing HRASG12V. To discern between
these possibilities, we attempted to restore TS and RR
levels in HRASG12V-WI-38 ﬁbroblasts after assessment of
senescence-associated phenotypes. To this end, we concur-
rently transduced WI-38 cells with cDNAs for TS, RR1, and
RR2 (hereafter TRR) or in parallel with three empty vectors
(hereafter 3V). Two days after infection, 3V and TRR cells
were superinfected with viruses that contained empty vector
or HRASG12V-expressing vector. Activity of HRASG12V in
3V and TRR cells was monitored by measuring the levels of
phosphorylated ERK1/2 that appeared to be the same in both144types of cells (Figure 2A). Expression of TS, RR1, and RR2
proteins was followed by Western blot analysis. As shown in
Figure 2A, superinfection of HRASG12V in TRR cells did not
signiﬁcantly change total (exogenous and endogenous)
amounts of these proteins. Consequently, dNTP levels in
HRASG12V-TRR cells were 2- to 2.5-fold higher than dNTP
levels in HRASG12V-3V cells (Figure 2B). Moreover, the
number of cells exhibiting DNA damage detected by the
comet assay or by staining with H2AX-gespeciﬁc antibodies
or the number of SA-b-Gal-positive cells was also two- toajp.amjpathol.org - The American Journal of Pathology
Figure 2 Coexpression of TS, RR1, and RR2
reduces OIS phenotypes in HRASG12V-WI38 ﬁbro-
blasts. A: Cells were infected with control vectors
three times (3V) or with vectors expressing cDNA
for TS, RR1, and RR2 cDNAs (TRR). Forty-eight
hours later, cells were superinfected with the
empty vector (V) or HRASG12V (RAS). Six days after
second infection, cells were harvested and lysed,
and total protein extracts were probed in Western
blot analysis with antibodies indicated on the left.
B: Cells were infected as in A. Six days after the
second infection, intracellular dNTPs were extrac-
ted and quantiﬁed. Amounts of each dNTP from
HRASG12V-infected cells were normalized by the
amounts of corresponding dNTP detected in 3V-
Vector cells or TRR-Vector cells. C: Cells were
infected as in A. Six days after infection, cells were
ﬁxed and processed to visualize SA-b-Gal activity,
ﬁxed and stained with H2AX-gespeciﬁc antibodies
and DAPI, or subjected to the comet assay (the
type of assay is shown on the left). Numbers
indicate percentage of positive cells in each assay.
The numbers were derived from counting cells in
multiple view ﬁelds. D and E: Cells were infected as
in A. Two days after second infection, cells were
plated in 12-well plates in triplicate and counted
every other day for 6 days. Numbers below the
graph correspond to the days after infection. In
parallel, at day 7 after infection, cells were assayed
for proliferation rates (EdU incorporation). In each
population, the number of positive cells was
divided by the number of total cells.
dNTP Pools Suppress Senescencethreefold lower in HRASG12V-TRR populations than in
HRASG12V-3V populations (Figure 2C). Most importantly,
inhibition of proliferation by HRASG12V in TRR cells was
only partial compared with the complete and stable prolifer-
ation arrest of HRASG12V-3V cells (Figure 2, D and E, andThe American Journal of Pathology - ajp.amjpathol.orgSupplemental Figure S1A). Thus, restoration of TS and RS
levels in cells overexpressing HRASG12V resulted in the
substantial suppression of senescence phenotypes.
To independently verify the importance of maintaining
high dNTP pools for suppression of DNA damage and OIS,145
Mannava et alwe attempted to restore intracellular dNTPs in WI-38-
HRASG12V cells by supplementing their culture media with
deoxyribonucleosides, starting the next day after infection
with HRASG12V-encoding virus, that is, before the emer-
gence of senescence-associated phenotypes. Culture media
with or without deoxyribonucleosides was replaced with the
fresh ones, respectively, with or without deoxyribonucleo-
sides, every 2 days for the duration of the experiment.
Incubation with deoxyribonucleosides did not affect the
activity of HRASG12V, as was determined by the absence of146changes in the amounts of phosphorylated ERK1/2 between
treated and untreated populations of cells (Figure 3A).
However, this treatment did increase intracellular amounts of
dNTP pools 1.5- to 2.5-fold (Figure 3B) and decreased the
number of H2AX-g- and comet-positive cells and cells that
exhibited SA-b-Gal activity in the treated populations
(Figure 3C). Accordingly, HRASG12V was less effective in
suppressing proliferation of WI-38 cells growing in the
medium supplemented with deoxyribonucleosides compared
with the untreated cells that underwent proliferation arrest
(Figure 3, D and E, and Supplemental Figure S1B). There-
fore, even partial restoration of suppressed dNTP pools via
either overexpression of TS and RR or incubation with
exogenous deoxyribonucleosides reduced DNA damage and
the full-scale manifestation of OIS in WI-38 cells.
To generalize our ﬁndings, we used a different type of
NHF, primary BJ ﬁbroblasts ectopically expressing the
human telomerase reverse transcriptase gene and
tamoxifen-inducible RASG12V-ERTAM chimeric gene (BJ-
ET-RASG12V-ERTAM cells). On activation of HRASG12V via
addition of 4-hydroxytestosterone (Figure 4A), proliferation
of these cells was reduced gradually until reaching an arrest
at approximately day 8 (Figure 4B). The arrest was
accompanied by changes in cell structure, increased
SA-b-Gal activity, and increased DNA damage that was
visualized by antibodies to H2AX-g (Figure 4C). At the
same time, continuous presence of deoxyribonucleosides in
growth media, although not affecting HRASG12V activation
(Figure 4A), reduced inhibition of cell proliferation and
other senescence-associated phenotypes (Figure 4, B and C)
similarly to WI-38 cells.
Depletion of TS and RR2 Causes Senescence in NHFs
To understand whether down-regulation of TS and RR
was sufﬁcient to cause DNA damage and emergence ofFigure 3 Exogenous deoxyribonucleosides reduce OIS phenotypes in
HRASG12V-WI38 ﬁbroblasts. A: Cells were infected with empty lentiviral
vector (V) or lentiviral vector encoding HRASG12V (R). Next day after
infection, 100 mmol/L of each deoxyribonucleoside was either added (þdN)
or not to the culture media, and media were replaced with the fresh one
with or without deoxyribonucleosides, respectively, every 2 days. Six days
after infection, cells were harvested and lysed, and total protein extracts
were probed in Western blot analysis with antibodies indicated on the left.
B: Cells were infected and treated as in A, followed by dNTP extraction and
quantiﬁcation 6 days after infection. All dNTP amounts were normalized by
the amounts detected in “vector” cells. C: Cells were infected and treated as
in A. Six days after infection, cells were ﬁxed and processed to visualize
SA-b-Gal activity or ﬁxed and stained with H2AX-gespeciﬁc antibodies and
DAPI or subjected to the comet assay (the type of assay is shown on the
left). Numbers indicate percentage of positive cells. The numbers were
derived from counting cells in multiple view ﬁelds. D and E: Cells were
infected and treated as in A. Two days after infection, cells were plated in
12-well plates in triplicate and counted every other day for 6 days. Numbers
below the graph correspond to the days after infection. In parallel, at day 6
after infection, cells were assayed for proliferation rates (EdU incorpora-
tion). In each population, the number of positive cells was divided by the
number of total cells.
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Figure 4 Exogenous deoxyribonucleosides reduce OIS phenotypes in
BJ-ET-RASG12V-ERTAM ﬁbroblasts. A: Untreated cells (UN), cells treated with
0.1 mmol/L 4-hydroxytestosterone (4-OHT), or with 4-hydroxytestosterone
and 100 mmol/L of each deoxyribonucleoside (4-OHTþdN). Seven days
after adding the chemicals, cells were harvested and lysed, and total
protein extracts were probed in Western blot analysis with antibodies
indicated on the left. B: Cells were plated in 12-well plates in triplicate and
treated as in A and counted every 2 days for 8 days. Numbers below
the graph correspond to the days after infection. C: Cells were treated as
in A for 7 days. Cells were ﬁxed and processed to visualize SA-b-Gal
activity or ﬁxed and stained with H2AX-gespeciﬁc antibodies and DAPI
(the type of staining is shown on the left). Numbers indicate percentage of
positive cells. The numbers were derived from counting cells in multiple
view ﬁelds.
dNTP Pools Suppress Senescencesenescent phenotypes in NHFs with normal, not
hyperstimulated, DNA replication, we depleted amounts of
TS and RR in WI-38 ﬁbroblasts via coinfection with
vectors that carried shRNAs for TS and RR subunit R2 and
compared these cells with cells infected with control
shRNA vector. Depletion of TS and RR2 (Figure 5A) led to
stable proliferation arrest (Figure 5B and Supplemental
Figure S1C), albeit with a longer latent period compared
with HRASG12V-WI-38 cells (9 to 11 days versus 4 to 6
days). Arrested ﬁbroblasts exhibited DNA damage as was
visualized by staining with antibodies to H2AX-g and
elevated activity of SA-b-Gal (Figure 5C); however, the
proportion of SA-b-Gal- and H2AX-g-positive cells was
also lower compared with WI-38 cells arrested by over-
expression of HRASG12V (compare Figures 2, 3, and 5).The American Journal of Pathology - ajp.amjpathol.orgOverexpression or TS and RR or Addition of Exogenous
Deoxyribonucleosides Does Not Suppress Quiescence in
NHFs
We were interested in addressing the role of TS and RR
overexpression in suppressing quiescence of NHFs, a form of
temporary arrest of DNA replication that was not associated
with DNA damage and could be achieved by serum depri-
vation.4,24 Incubation of WI-38 cells in medium devoid of
fetal bovine serum for 48 hours resulted in substantial down-
regulation of TS, RR1, and RR2 (Figure 6A); however, no
increasewas detected in the number ofH2AX-g-positive cells
(Figure 6B), suggesting that no DNA damage was present.
Importantly, continuous supplementation with deoxy-
ribonucleosides of fetal bovine serum-free culture media did
not even partially affect proliferation arrests as was deter-
mined by EdU incorporation at day 5 after replacing the
culture medium (Figure 6C). Accordingly, the same assay
showed that proliferation of TRR-expressing WI-38 cells
(described above) was suppressed by serum withdrawal
as efﬁciently as the proliferation of control 3V cells
(Figure 6C). Thus, we concluded that, unlike OIS, over-
expression of TS and RR or supplementation with deoxy-
ribonucleosides did not suppress quiescence in NHFs.
Promoters of TS, RR1, and RR2 Interact with RB and
Undergo Heterochromatization in Senescent HRASG12V-
WI38 Cells
Transcription levels of RR1, RR2, and TS can be up-
regulated by ectopic expression of E2F1.25 Promoters of
some E2F-responsive genes have been shown to interact
with RB tumor suppressor proteins in NHFs undergoing
HRASG12V-induced senescence.26 Thus, to identify whether
silencing of TRR genes in HRASG12V-WI38 senescent
ﬁbroblasts occurs via interactions with RB, we performed
chromatin immunoprecipitation in these and vector cells
with control antibodies, antibodies to RB, or H3K93Me,
a hallmark of heterochromatin27 and senescence-associated
heterochromatin foci.26 After precipitation, the chromatin
was de-crosslinked, and the puriﬁed DNA was probed in
semiquantitative PCR with primers that spanned E2F1-
binding sites in the promoters of RR1, RR2, and TS genes.
By this method, we demonstrated substantial enrichment of
the promoter regions of all three genes in chromatin
precipitated with RB- or H3K93Me-speciﬁc antibodies from
HRASG12V-senescent but not vector cells (Figure 7), sug-
gesting that RB binding and formation of heterochromatin
contributed to silencing of TRR genes in senescent
HRASG12V-WI38 cells.Discussion
DNA damage induced by ectopic expression of activated
RAS or RAF oncoproteins in normal mammalian cells has147
Figure 5 Deﬁciency of TS and RR2 induces senescence in WI-38
ﬁbroblasts. A: Cells were infected with control shRNA lentiviral vector
(Cl) or with combination of vectors carrying shRNAs for TS or RR2 shRNAs
(TþR2). Two days after infection, cells were harvested and lysed, and total
protein extracts were probed in Western blot analysis with antibodies
indicated on the left. B: Cells were infected as in A. Two days after
infection, cells were plated in 12-well plates in duplicate and counted every
other day for 9 days. Numbers below the graph correspond to the days after
infection. C: Cells were infected as in A. Ten days after infection, cells were
ﬁxed and processed to visualize SA-b-Gal activity or ﬁxed and stained with
H2AX-gespeciﬁc antibodies and DAPI (type of assay is shown on the left).
Numbers indicate percentage of positive cells. The numbers were derived
from counting cells in multiple view ﬁelds.
Mannava et albeen considered as a main cause of senescence, a fail-safe
mechanism for suppressing tumor development at a prema-
lignant stage.1,2 In the present study, we tested the
hypothesis that at least one of the main mediators of
HRASG12V DNA damage- and senescence-inducing activity148is down-regulation of dNTP pools. Decrease in the amounts
of intracellular deoxyribonucleotides in OIS cells may cause
DNA damage and affect DNA replication fork progression
(which was described in ﬁbroblasts undergoing HRASG12V-
induced senescence6) via several interrelated mechanisms.
The most obvious one is that dNTP deﬁciency slows
processivity or even completely arrests DNA polymerase.
However, this is an unlikely scenario because inhibition of
DDR proteins ATM or CHK2 abolishes HRASG12V-
induced senescence in NHFs, presumably via a dNTP-
independent mechanism.4e7 Most likely, stalling or
collapse of the replication fork in a senescent cell occurs
because of the DNA damage sites preexistent to the current
DNA replication, and these preexistent lesions may origi-
nate from dNTP depletion. For example, it has been shown
that inhibition of TS activity results in depletion of dTTP
pools and in symmetrical increase in the amounts of deoxy-
uridine triphosphates, which are used instead of dTTP for
DNA polymerization.28 The incorporated uracil is removed
via the uracil base excision repair system; however, if the
number of incorporated uracil bases is high, the repair
machinery is overwhelmed and generates abasic sites, as
well as DSBs and/or SSBs,15 which would ultimately cause
replication stress and would affect the replication fork
progression during the following round of DNA replication.
Similarly, inhibition of RR and subsequent depletion of
dATP, dGTP, and dCTP pools leads to nucleotide mis-
incorporation and activation of the mismatch repair
system29 that, if overwhelmed, would also generate DSBs
and/or SSBs.30 In addition, both base excision repair and
mismatch repair systems use de novo DNA synthesis to ﬁll
the gaps generated in the course of DNA repair.31 Low
levels of dNTPs would affect ﬁdelity of this synthesis and
subsequently DNA repair in general.
The proposed mechanisms of generation of DNA damage
in OIS cells are in good agreement with previously pub-
lished observations. For instance, as was mentioned above,
a large number of HRASG12V-expressing cells were arrested
with partly replicated DNA, suggesting stalling or a collapse
of replication fork.6 DNA hyperreplication (multiple ﬁring
of the same replication origin) was proposed to be a primary
cause for this phenotype.6 Stalling or collapse of the repli-
cation fork and subsequent induction of the S-phase
checkpoint can be induced by pharmacologic inhibition of
TS or RR via mechanisms described above in cells with
normal, not hyperstimulated, DNA replication. Therefore, it
is conceivable that, under the conditions of low dNTP pools,
multiple origin ﬁrings and subsequently multiple replication
forks would generate even higher DNA damage.
Accordingly, fragile sites in OIS cells were more prone to
undergoing mutations than any other regions of the
genome.6 Similarly, pharmacologic inhibition of RR has
been shown to disproportionate increase mutagenesis of
genomic regions that contain fragile sites.32,33
We demonstrated that even partial restoration of depleted
intracellular dNTP pools is sufﬁcient for substantialajp.amjpathol.org - The American Journal of Pathology
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Figure 7 Promoter regions of TS, RR1, and RR2 are enriched with RB
and H3K93Me. A: Cells were infected with empty lentiviral vector or lentiviral
vector encoding HRASG12V. Six days after infection, cells were harvested and
lysed, and total protein extracts were probed in Western blot analysis with
antibodies shown on the left. B: Cells were infected as in A. Six days after
infection, cells were cross-linked and lysed, and chromatin was immuno-
precipitated with the antibodies shown on the top, followed by the reversal
of the cross-linking and DNA isolation. DNA obtained from chromatin
immunoprecipitated with the antibodies designated on the top, or 0.1% of
the input DNA (Inp.), was used in PCR with the primers speciﬁc to the
promoter regions of the genes shown on the left.
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Figure 6 Coexpression of TS, RR1, and RR2 or addition of exogenous deoxyribonucleosides does not affect quiescence of WI-38 ﬁbroblasts. A: Cells were
incubated in culture medium containing 10% or 0% fetal bovine serum (FBS) for 2 days. Cells were collected and lysed, and total protein extracts were probed
in Western blot analysis with antibodies indicated on the left. B: Cells treated as in A were ﬁxed and stained with antibodies for H2AX-g. The numbers were
derived from counting cells in multiple view ﬁelds. C: Uninfected WI-38 cells, 3V WI-38 cells, and TRR WI-38 cells were grown in the media containing 10%
(black bars) or 0% (white bars) FBS supplemented or not with 100 mmol/L deoxyribonucleosides (þdN) for a period of 5 days. Cell proliferation was assessed by
EdU incorporation assay. The numbers were derived from counting cells in multiple view ﬁelds.
dNTP Pools Suppress Senescencesuppression of DNA damage and senescence. Despite
signiﬁcant ectopic overexpression of TS and RR or incuba-
tion with excessive amounts of deoxyribonucleosides, we
were unable to completely restore dNTP pools in cells
undergoing senescence. Complete reconstitution may require
involvement of salvage pathway enzymes (especially for
phosphorylation of exogenously added nucleosides) that,
like thymidine kinase 121 (Figure 1C), may be suppressed in
senescent cells or enzymes involved in biosynthesis of
ribonucleotides. Interestingly, the genomes of herpes viruses
that replicate their DNA in quiescent cells with depleted
dNTP pools often encode enzymes for both de novo and
salvage pathways, including homologues to cellular RR1
and RR2, TS, thymidine kinase, dihydrofolate reductase, and
dUTP pyrophosphatase.34 However, we could not recapitu-
late expression of all of these genes in our experimental
settings because overexpression of additional cDNAs in WI-
38 cells affected their normal proliferation rates.
It is known that transformed cells use aerobic glycolysis
as a major pathway for biosynthesis of adenosine triphos-
phate, a process called the Warburg effect.35 Several groups
reported that the enhanced rates of glycolysis occur largely
because of the increased demand of a transformed cell
for macromolecule components, including nucleotides
that can be synthesized from glycolytic metabolites.36,37
Bypassing senescence is considered an initial step in
oncogenic transformation, and our data suggest that eleva-
tion of nucleotide levels is an important prerequisite for this
step. Thus, switching to aerobic glycolysis to increase
nucleotide pools may be required already at early stages of
tumorigenesis.
Our results suggest that both nucleotide depletion and
active DNA replication are required for efﬁcient induction
of DNA damage and OIS. Concurrent depletion of TS and
RR2 in WI-38 ﬁbroblasts with normal DNA replication
induced senescence with longer latent period thanThe American Journal of Pathology - ajp.amjpathol.orgoverexpression of HRASG12V, and senescent populations
contained lower fractions of H2AX-g-positive and SA-b-
Gal-positive cells than WI-38 cells overexpressing
HRASG12V (with presumably hyperreplicated DNA)
(Figures 2 and 5). Furthermore, serum withdrawal-arrested
WI-38 cells, with no DNA replication, do not undergo
DNA damage and senescence despite down-regulation of
TS, RR1, and RR2 (Figure 5). Accordingly, ectopic over-
expression of these enzymes in quiescent WI-38 cells or
exogenous addition of deoxyribonucleosides into their
media did not overcome this form of proliferation arrest.149
Mannava et alWe demonstrated that promoters of TS, RR1, and RR2 in
HRASG12V-WI38 senescent cells interacted with RB tumor
suppressor proteins and were enriched with heterochromatin
marker H3K93Me (Figure 7). RB has been shown to play an
essential role in HRASG12V-induced senescence by binding
to the promoters of several E2F-responsive genes and by
establishing repressive chromatin at the target loci.26 Thus,
our ﬁndings may offer a novel connection between RB
activation and repression of nucleotide metabolism, ulti-
mately resulting in the increased DNA damage and
senescence. Taken together, our data provide a previously
unidentiﬁed mechanism for the induction of DNA damage
and OIS.
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